Could a simple steroid help tiniest babies escape the ventilator?
NCT ID NCT07447739
First seen Mar 16, 2026 · Last updated May 22, 2026 · Updated 7 times
Summary
This study looks at whether giving the steroid betamethasone to extremely premature babies (born before 28 weeks) can help them come off a breathing machine faster and lower their risk of chronic lung disease. About 100 babies will either receive the drug or standard care, and doctors will track their breathing progress and any side effects like high blood sugar or blood pressure. The goal is to find a safer way to support lung development in the most vulnerable newborns.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY DISTRESS SYNDROME (RDS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maria Fareri Children's Hospital at Westchester Medical Center
Valhalla, New York, 10595, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.